BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 1890369)

  • 21. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
    Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil.
    Frota CC; Freitas MV; Foss NT; Lima LN; Rodrigues LC; Barreto ML; Kerr LR
    Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):490-5. PubMed ID: 20447668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
    Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroepidemiological study of leprosy in a highly endemic population of south India based on an ELISA using synthetic PGL-I.
    Krishnamurthy P; Rao PS; Reddy BN; Subramanian M; Dhandayudapani S; Bhatia V; Neelan PN; Dutta A
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):426-31. PubMed ID: 1890366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
    Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
    Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early infection with M. leprae and antibodies to phenolic glycolipid-I in the nine-banded armadillo.
    Job CK; Drain V; Truman RW; Sanchez RM; Hastings RC
    Indian J Lepr; 1990; 62(2):193-201. PubMed ID: 2212734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gelatin particle agglutination assay to detect anti-PGL-I antibodies in leprosy patients and in household contacts: a preliminary study.
    Mahajan P; Jogaikar DG; Jadhav VH; Mehta JM
    Indian J Lepr; 1992; 64(4):461-7. PubMed ID: 1308520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of monitoring antibodies to PGL-I in armadillos experimentally infected with M. leprae.
    Truman RW; Morales MJ; Shannon EJ; Hastings RC
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):556-9. PubMed ID: 3546545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
    Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological activity of natural disaccharide octyl bovine serum albumin (ND-O-BSA) in sera from patients with leprosy, tuberculosis, and normal controls.
    Wu QX; Ye GY; Li XY
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):50-5. PubMed ID: 3131466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
    Schwerer B; Meeker HC; Sersen G; Levis WR
    Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis.
    David HL; Papa F; Cruaud P; Berlie HC; Maroja MF; Salem JI; Costa MF
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):208-24. PubMed ID: 1522363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.
    David HL; Maroja M F; Cruaud P
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):332-4. PubMed ID: 2071994
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
    Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
    Spencer JS; Kim HJ; Wheat WH; Chatterjee D; Balagon MV; Cellona RV; Tan EV; Gelber R; Saunderson P; Duthie MS; Reece ST; Burman W; Belknap R; Mac Kenzie WR; Geluk A; Oskam L; Dockrell HM; Brennan PJ;
    Clin Vaccine Immunol; 2011 Feb; 18(2):260-7. PubMed ID: 21177913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.